Belpointe Asset Management LLC Novartis Ag Transaction History

Belpointe Asset Management LLC

  • $1.51 Billion
  • Q4 2024

A detailed history of Belpointe Asset Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Belpointe Asset Management LLC holds 5,707 shares of NVS stock, worth $610,135. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,707
Previous 4,320 32.11%
Holding current value
$610,135
Previous $496,000 11.9%
% of portfolio
0.04%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$96.78 - $117.18 $134,233 - $162,528
1,387 Added 32.11%
5,707 $555,000
Q3 2024

Nov 12, 2024
SELL
$106.13 - $120.89 $122,261 - $139,265
-1,152 Reduced 21.05%
4,320 $496,000
Q2 2024

Aug 02, 2024
BUY
$92.57 - $107.37 $506,543 - $587,528
5,472 New
5,472 $582,000
Q3 2023

Nov 15, 2023
BUY
$94.73 - $105.13 $21,977 - $24,390
232 Added 11.24%
2,296 $233,000
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $329,926 - $374,109
-3,566 Reduced 63.34%
2,064 $208,000
Q1 2023

May 15, 2023
BUY
$80.03 - $92.81 $23,448 - $27,193
293 Added 5.49%
5,630 $517,000
Q4 2022

Feb 08, 2023
BUY
$75.55 - $92.52 $206,478 - $252,857
2,733 Added 104.95%
5,337 $484,000
Q3 2022

Nov 14, 2022
BUY
$74.61 - $87.26 $2,014 - $2,356
27 Added 1.05%
2,604 $197,000
Q2 2022

Aug 02, 2022
SELL
$80.52 - $93.75 $7,729 - $9,000
-96 Reduced 3.59%
2,577 $218,000
Q1 2022

Apr 28, 2022
BUY
$80.11 - $90.62 $23,952 - $27,095
299 Added 12.59%
2,673 $235,000
Q4 2021

Feb 15, 2022
BUY
$79.7 - $88.13 $54,833 - $60,633
688 Added 40.81%
2,374 $208,000
Q3 2021

Nov 15, 2021
BUY
$81.78 - $95.14 $13,084 - $15,222
160 Added 10.48%
1,686 $138,000
Q2 2021

Aug 09, 2021
SELL
$85.24 - $94.15 $4,262 - $4,707
-50 Reduced 3.17%
1,526 $140,000
Q1 2021

May 14, 2021
SELL
$83.5 - $98.47 $33,650 - $39,683
-403 Reduced 20.36%
1,576 $134,000
Q4 2020

Feb 16, 2021
SELL
$78.07 - $94.43 $58,708 - $71,011
-752 Reduced 27.54%
1,979 $187,000
Q3 2020

Nov 13, 2020
BUY
$82.14 - $91.0 $23,492 - $26,026
286 Added 8.45%
3,669 $302,000
Q3 2020

Nov 13, 2020
SELL
$82.14 - $91.0 $77,047 - $85,358
-938 Reduced 25.57%
2,731 $238,000
Q2 2020

Jul 20, 2020
SELL
$80.93 - $91.1 $23,145 - $26,054
-286 Reduced 7.8%
3,383 $296,000
Q1 2020

Jul 20, 2020
SELL
$70.67 - $99.01 $28,692 - $40,198
-406 Reduced 9.96%
3,669 $302,000
Q4 2019

Feb 18, 2020
BUY
$84.35 - $95.37 $129,139 - $146,011
1,531 Added 60.18%
4,075 $386,000
Q3 2019

Jan 16, 2020
BUY
$85.54 - $94.26 $217,613 - $239,797
2,544 New
2,544 $221,000
Q4 2018

Mar 06, 2019
SELL
$73.66 - $82.02 $111,889 - $124,588
-1,519 Closed
0 $0
Q3 2018

Nov 23, 2018
BUY
$66.94 - $77.43 $101,681 - $117,616
1,519 New
1,519 $131,000

Others Institutions Holding NVS

# of Institutions
1,471
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $230B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email